国产在线一区二区三区AV,国产AV天堂无码一区二区三区,黄色电影免费观看,国内精品久久久久久99蜜桃

Stock(600222)Hot line:010-61006450

MAH

Leader of "0" Cost MAH 3.0 Era

Platform Overview

Platform Overview
————???????—???????—???????—???????—???????—???????—

 
The project Initiation service platform has more than 20 professional knowledge personnel, all from Shenyang Pharmaceutical University, Chinese Academy of Medical Sciences, Peking Union Medical College and other well-known universities at home and abroad, and has set up generic drug project strategy center, clinical & pharmacology center, intellectual property center, big data analysis center, international new product strategy center, based on the all-round analysis of the pharmaceutical industry and combined with the company's own differentiated positioning, can provide customers with personalized information technology services and comprehensive information assurance.

 Service Content

—???????—???????—???????—???????—???????—???????—???????—???????—???????—

1) Generic Drug Project Initiation: Project development risk assessment is carried out through comprehensive analysis of listed product information, including review overview, patents, market prospects, competition pattern, technical barriers, policy dynamics and other mainstream regulatory countries in Europe, the United States, Japan, China, Canada, Australia and other mainstream regulatory countries.
???????

2)Improvement and Innovation Projects: According to the domestic clinical needs and the guidance of policies and regulations, look for potential improvement and innovation projects, conduct comprehensive research from the aspects of product clinical positioning, market value, competition dynamics, patent layout, and development and listing paths of such projects at home and abroad, determine the adequacy and feasibility of the basis for the topic, and conduct in-depth pharmaceutical technology evaluation, clinical evaluation, development cycle and cost evaluation of the proposed development project.
 

3) Strategy Consulting Service: According to the needs of enterprises, provide partners with product pipeline sustainable development planning, feasibility analysis of new entry fields, and R&D strategy formulation after policy changes, such as the development opportunities and challenges in the cardiovascular field, the key points of improved new drug technology research and development, the analysis of the clinical drug competition pattern of platforms (ophthalmic preparations, enteric-coatedpreparations, sustained-release preparations), and the monthly analysis report of CDE application acceptance products.
 

4)Patent Service: Patent layout of cooperation projects, patent risk assessment of new products, infringement analysis and circumvention strategies, patent search and analysis service, patent tracking and early warning analysis.

5)Resource sharing: The leadingpharm information department cooperates with many well-known pharmaceutical databases at home and abroad (cortellis, intranet, insight, wisdombud), which can provide domestic and foreign listing information, the latest information on industry policies, new products/targets at home and abroad, domestic and foreign product sales and forecast data, market access, clinical guidelines and clinical front-line drug consultation, etc.


 

 

 

 

 

 

 

国产永久免费crm系统| 国产男女无遮挡猛进猛出 | 亚洲成AV人片在线观看无 | 日韩乱码人妻无码系列中文字幕 | 亚洲色婷婷一区二区三区| 一二三四免费bd高清视频| 久久久久久精品久久久| 末成年女av片一区二区| 亚洲国产一区二区精品专区发布| 国产精品久久久久久AV| 亚洲乱码av中文一区二区| 久久亚洲国产成人影院| 久久久www成人免费毛片| 国产精品永久免费视频| 无码少妇精品一区二区免费| 在线看免费做爰60分钟视频| 亚洲乱码中文字幕久久孕妇黑人 | 人妻无码一区二区三区四区| 国产无套流白浆视频免费| 人妻含泪握住粗大| 久久久久精品国产亚洲AV麻豆 | 日韩电影免费在线观看网址| 天堂资源中文最新版在线一区| 国产精品国产三级国产专播| 午夜精品久久久久久久99热蜜桃 | 蜜桃色欲AV久久无码精品| 男人狂躁进女人免费视频| 性生交大片免费| 亚洲精品无码成人久久久| 野花免费高清完整在线观看| 天天综合亚洲色在线精品| 成人国产片女人爽到高潮网站 | 青青河边草免费视频观看| 99精品丰满人妻无码A片| 亚欧美无遮挡HD高清在线视频 | 日日麻批免费40分钟无码| 精品无码一区二区三区爱欲| 亚洲小鲜肉与欧美猛男的区别| 亚洲老熟女AV一区二区在线播放 | 亚洲av精品一区二区三区| 成人做爰69片免费看网站|